| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.078 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |